These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2132940)

  • 1. Immunological aspects of the autonomous behaviour of tumours.
    Glushkov AN
    Biomed Sci; 1990; 1(6):565-70. PubMed ID: 2132940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies as oncogenes: a hypothesis.
    Admon A; Shoshan SH
    Med Hypotheses; 2006; 67(3):471-3. PubMed ID: 16632230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic natural antibodies against human tumours: an option for anti-cancer immunotherapy?
    Schwartz-Albiez R; Laban S; Eichmüller S; Kirschfink M
    Autoimmun Rev; 2008 Jun; 7(6):491-5. PubMed ID: 18558368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of unstimulated and thrombin-activated platelets to human tumour cells.
    Sagawa T; Tominaga A; Kodama T; Okada M
    Immunology; 1993 Apr; 78(4):650-6. PubMed ID: 8495982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD3 directed bispecific antibodies induce increased lymphocyte-endothelial cell interactions in vitro.
    Molema G; Tervaert JW; Kroesen BJ; Helfrich W; Meijer DK; de Leij LF
    Br J Cancer; 2000 Jan; 82(2):472-9. PubMed ID: 10646907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated lymphocytes promote endothelial cell detachment from matrix: a role for modulation of endothelial cell beta 1 integrin affinity.
    Phan C; McMahon AW; Nelson RC; Elliott JF; Murray AG
    J Immunol; 1999 Oct; 163(8):4557-63. PubMed ID: 10510399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current aspects of tumor immunology].
    Donat H; Schiller S
    Zentralbl Gynakol; 1986; 108(19):1153-63. PubMed ID: 2433851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth.
    Bei R; Masuelli L; Palumbo C; Modesti M; Modesti A
    Cancer Lett; 2009 Aug; 281(1):8-23. PubMed ID: 19091462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of mast cell interactions with blood vessel wall components by direct contact with intact T cells or T cell membranes in vitro.
    Brill A; Baram D; Sela U; Salamon P; Mekori YA; Hershkoviz R
    Clin Exp Allergy; 2004 Nov; 34(11):1725-31. PubMed ID: 15544597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central issues in present-day tumor immunology: interpretation of lymphocytotoxicity assays and the demonstration of auto-tumor-reactive lymphocytes in patients.
    Klein E
    Transplant Proc; 1981 Mar; 13(1 Pt 2):723-8. PubMed ID: 6168071
    [No Abstract]   [Full Text] [Related]  

  • 11. An introduction to tumour immunology.
    James K
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):795-808. PubMed ID: 6611141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Natural cytotoxic cells (NK) and their role in the immunological control of neoplasms].
    Rupniewska ZM; Adamczyk MB
    Postepy Hig Med Dosw; 1981; 35(1):37-52. PubMed ID: 6174960
    [No Abstract]   [Full Text] [Related]  

  • 13. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R; Yoneda Y; Kuriyama M; Kubota T
    J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factors, cell proliferation and cancer: an overview.
    Rozengurt E
    Mol Biol Med; 1983 Jul; 1(1):169-81. PubMed ID: 6092824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunological properties of tumor cells that determine the degree of their malignancy].
    Lavrovskiĭ VA; Viksler VKh
    Usp Sovrem Biol; 1981; 91(2):228-40. PubMed ID: 7018110
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytotoxic lymphocytes: redirecting the cell-mediated immune response for the therapy of cancer.
    Kershaw MH; Trapani JA; Smyth MJ
    Ther Immunol; 1995 Jun; 2(3):173-81. PubMed ID: 8885135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biological aspects of the recurrence of malignant tumors].
    Konovalova NP; Soliakova TI
    Eksp Onkol; 1988; 10(2):9-14. PubMed ID: 3292216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of leucocyte function-associated antigen-1 and 7F7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin lymphomas and leukaemias: possible influence on growth pattern and leukaemic behaviour.
    Stauder R; Greil R; Schulz TF; Thaler J; Gattringer C; Radaskiewicz T; Dierich MP; Huber H
    Clin Exp Immunol; 1989 Aug; 77(2):234-8. PubMed ID: 2673591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activating anti-CD40 antibodies induce tumour invasion by cytotoxic T-lymphocytes and inhibition of tumour growth in experimental liver cancer.
    Ryschich E; Märten A; Schmidt E; Linnebacher M; Wentzensen N; Eisold S; Klar E; Büchler MW; Schmidt J
    Eur J Cancer; 2006 May; 42(7):981-7. PubMed ID: 16564167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recruitment and proliferation of T lymphocytes is supported by IFNgamma- and TNFalpha-activated human osteoblasts: Involvement of CD54 (ICAM-1) and CD106 (VCAM-1) adhesion molecules and CXCR3 chemokine receptor.
    Lisignoli G; Toneguzzi S; Piacentini A; Cristino S; Cattini L; Grassi F; Facchini A
    J Cell Physiol; 2004 Mar; 198(3):388-98. PubMed ID: 14755544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.